Axsome Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, AXSM, Axsome Therapeutics Inc, priceseries

Axsome Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
29.68
Close
28.85
High
30.51
Low
28.39
Previous Close
29.91
Daily Price Gain
-1.06
YTD High
38.42
YTD High Date
Jan 3, 2022
YTD Low
21.85
YTD Low Date
Jan 24, 2022
YTD Price Change
-8.98
YTD Gain
-23.74%
52 Week High
74.10
52 Week High Date
Jun 28, 2021
52 Week Low
19.38
52 Week Low Date
Aug 19, 2021
52 Week Price Change
-33.97
52 Week Gain
-54.08%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 16. 2017
4.10
Jul 3. 2017
5.15
11 Trading Days
25.64%
Link
LONG
Sep 15. 2017
4.95
Oct 10. 2017
5.74
17 Trading Days
15.91%
Link
LONG
Apr 26. 2018
3.00
May 21. 2018
3.33
17 Trading Days
11.00%
Link
LONG
Aug 28. 2018
3.00
Sep 10. 2018
3.15
8 Trading Days
5.10%
Link
LONG
Oct 15. 2018
3.35
Nov 5. 2018
3.90
15 Trading Days
16.38%
Link
LONG
Jan 30. 2019
8.33
Feb 7. 2019
8.78
6 Trading Days
5.43%
Link
LONG
Mar 6. 2019
8.86
Apr 1. 2019
12.84
18 Trading Days
44.90%
Link
LONG
Apr 22. 2019
15.12
May 23. 2019
21.39
23 Trading Days
41.48%
Link
LONG
Sep 11. 2019
25.18
Sep 23. 2019
27.16
8 Trading Days
7.87%
Link
LONG
Nov 13. 2019
25.70
Jan 3. 2020
93.83
34 Trading Days
265.08%
Link
LONG
Apr 22. 2020
69.88
May 8. 2020
88.79
12 Trading Days
27.06%
Link
LONG
Jun 17. 2021
66.54
Jun 29. 2021
70.05
8 Trading Days
5.27%
Link
LONG
Sep 15. 2021
27.72
Oct 4. 2021
32.73
13 Trading Days
18.08%
Link
LONG
Oct 11. 2021
32.62
Oct 25. 2021
39.47
10 Trading Days
21.00%
Link
LONG
Dec 16. 2021
33.51
Dec 29. 2021
35.23
8 Trading Days
5.13%
Link
LONG
Feb 4. 2022
28.71
Feb 17. 2022
31.04
9 Trading Days
8.11%
Link
Company Information
Stock Symbol
AXSM
Exchange
NasdaqGM
Company URL
http://www.axsome.com
Company Phone
212-203-5072
CEO
Herriott Tabuteau
Headquarters
New York
Business Address
25 BROADWAY, 9TH FLOOR, NEW YORK, NY 10004
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001579428
About

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Description

Developing an oral formulation of an existing therapy for pain and osteoarthritis.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading